INS and type 2 diabetes mellitus: In fact, in contrast to serum C-peptide levels, FINS levels were seldom measured, and doing so is usually considered unnecessary for insulin- or insulin analog-treated patients with type 2 diabetes, because serum C-peptide levels reflect endogenous insulin secretion, whereas FINS levels include both endogenous and exogenous insulin.